AU2002223044A1 - Kit and method for detecting the esm-1 protein - Google Patents

Kit and method for detecting the esm-1 protein

Info

Publication number
AU2002223044A1
AU2002223044A1 AU2002223044A AU2304402A AU2002223044A1 AU 2002223044 A1 AU2002223044 A1 AU 2002223044A1 AU 2002223044 A AU2002223044 A AU 2002223044A AU 2304402 A AU2304402 A AU 2304402A AU 2002223044 A1 AU2002223044 A1 AU 2002223044A1
Authority
AU
Australia
Prior art keywords
amino acid
protein
esm
kit
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002223044A
Inventor
David Bechard
Philippe Lassalle
Andre-Bernard Tonnel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut Pasteur de Lille
Publication of AU2002223044A1 publication Critical patent/AU2002223044A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Abstract

The invention concerns a kit for the detection of protein ESM-1 in a sample, comprising: a) a first antibody specifically binding to the N-terminal region of protein ESM-1 contained between the amino acid in position 20 and the amino acid in position 78 of the amino acid sequence of this protein; and b) a second antibody specifically binding to the C-terminal region contained between the amino acid in position 79 and the amino acid in position 184 of the amino acid sequence of protein ESM-1.
AU2002223044A 2000-11-09 2001-11-08 Kit and method for detecting the esm-1 protein Abandoned AU2002223044A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0014421 2000-11-09
FR0014421A FR2816410B1 (en) 2000-11-09 2000-11-09 ESM-1 PROTEIN DETECTION KIT AND DETECTION METHOD USING THE SAME
PCT/FR2001/003477 WO2002039123A1 (en) 2000-11-09 2001-11-08 Kit and method for detecting the esm-1 protein

Publications (1)

Publication Number Publication Date
AU2002223044A1 true AU2002223044A1 (en) 2002-05-21

Family

ID=8856264

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002223044A Abandoned AU2002223044A1 (en) 2000-11-09 2001-11-08 Kit and method for detecting the esm-1 protein

Country Status (13)

Country Link
US (1) US7473564B2 (en)
EP (1) EP1336109B1 (en)
JP (1) JP4290424B2 (en)
AT (1) ATE366420T1 (en)
AU (1) AU2002223044A1 (en)
CA (1) CA2428368A1 (en)
CY (1) CY1106876T1 (en)
DE (1) DE60129239T2 (en)
DK (1) DK1336109T3 (en)
ES (1) ES2290193T3 (en)
FR (1) FR2816410B1 (en)
PT (1) PT1336109E (en)
WO (1) WO2002039123A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076499A2 (en) * 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
KR20040049830A (en) * 2001-07-09 2004-06-12 애프톤 코포레이션 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
EP1565552A4 (en) * 2002-07-01 2006-05-10 Pharmacia Corp Esm-1 gene differentially expressed in angiogenesis, antagonists thereof, and methods of using the same
US7235376B2 (en) * 2003-03-28 2007-06-26 Receptor Biologix, Inc. Gastrin hormone immunoassays
EP1634176B1 (en) 2003-06-18 2014-07-02 Fujitsu Technology Solutions Intellectual Property GmbH Cluster arrangement
AU2005228897B2 (en) * 2004-03-29 2009-12-10 Cancer Advances, Inc. Monoclonal antibodies to gastrin hormone
KR101333168B1 (en) * 2004-09-22 2013-11-28 리셉터 바이오로직스 인크 Monoclonal antibodies to progastrin
ES2316293B1 (en) * 2007-07-27 2010-02-05 Institut De Reserca Hospital Universitari Vall D'hebron METHOD FOR DETECTING AN ENDOTELIAL DYSFUNCTION.
KR101058753B1 (en) * 2007-11-22 2011-08-24 한국생명공학연구원 Characterization of ESM-1 as a tumor associated marker of colorectal cancer
US20120015387A1 (en) * 2008-10-08 2012-01-19 Inserm (Institut National De La Sante Et De La Recherche Medicale) Marker peptides for determining the occurrence of an inflammatory state in a subject
SG10201600502XA (en) * 2011-01-21 2016-02-26 Inserm Inst Nat De La Santé Et De La Rech Médicale Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood
CA2903929A1 (en) * 2013-03-04 2014-09-12 Iq Products B.V. Prognostic marker to determine the risk for early-onset preeclampsia
TWI772927B (en) * 2015-03-31 2022-08-01 德商英麥提克生物技術股份有限公司 Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (rcc) and other cancers
EP3279665B1 (en) 2016-08-04 2020-07-08 Roche Diagniostics GmbH Circulating esm-1 (endocan) in the assessment of atrial fibrillation
WO2022034162A1 (en) 2020-08-14 2022-02-17 F. Hoffmann-La Roche Ag Esm-1 for the assessment of silent brain infarcts and cognitive decline
FR3135892A1 (en) 2022-05-30 2023-12-01 Biothelis treatment of acute respiratory distress syndrome (ARDS) in a patient

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506111A (en) * 1989-02-10 1996-04-09 Teijin Limited Method of immunological assaying of human osteocalcin, reagent and kit therefor, antibody to human osteocalcin, hybridoma producing said antibody, and method of producing it
US5747280A (en) 1995-06-05 1998-05-05 Human Genome Sciences, Inc. Human vascular IBP-like growth factor
WO1996017931A1 (en) 1994-12-09 1996-06-13 Human Genome Sciences, Inc. Human vascular ibp-like growth factor
US6670328B1 (en) * 1997-06-24 2003-12-30 Institut Pasteur De Lille Proteins and peptides derived from protein ESM-1 and their uses in the treatment and diagnosis of diseases linked to leukocyte migration
FR2775691B1 (en) * 1998-03-05 2000-12-15 Pasteur Institut SPECIFIC MONOCLONAL ANTIBODIES OF ESM-1 PROTEIN, AND USE OF SUCH ANTIBODIES FOR DETECTION OF ESM-1 PROTEIN

Also Published As

Publication number Publication date
EP1336109A1 (en) 2003-08-20
CY1106876T1 (en) 2012-09-26
FR2816410A1 (en) 2002-05-10
DE60129239D1 (en) 2007-08-16
US20040063164A1 (en) 2004-04-01
US7473564B2 (en) 2009-01-06
FR2816410B1 (en) 2003-04-18
CA2428368A1 (en) 2002-05-16
EP1336109B1 (en) 2007-07-04
JP4290424B2 (en) 2009-07-08
PT1336109E (en) 2007-09-24
DK1336109T3 (en) 2007-10-15
ES2290193T3 (en) 2008-02-16
WO2002039123A1 (en) 2002-05-16
DE60129239T2 (en) 2008-03-13
JP2004522941A (en) 2004-07-29
ATE366420T1 (en) 2007-07-15

Similar Documents

Publication Publication Date Title
AU2002223044A1 (en) Kit and method for detecting the esm-1 protein
EP2270040A3 (en) Binding polypeptides for B lymphocyte stimulator protein (BLyS)
WO2004033631A8 (en) Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
WO2002032925A3 (en) Protein scaffolds for antibody mimics and other binding proteins
WO1999058571A3 (en) Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
WO2005051998A3 (en) Antibodies binding to a c-terminal fragment of apolipoprotein e
AU6162999A (en) Apoptosis marker antibodies and methods of use
WO2002042427A3 (en) Mass tags for quantitative analysis
EP2275818A3 (en) Method for improved early recognition of the seroconversion of an antibody to hepatitis C
AU2126400A (en) Detection of small molecules by use of a piezoelectric sensor
EP1652918A3 (en) Methods for detecting protein interactions using conformationally constrained peptides
AU3623197A (en) Peptide reagent for the detection of human cytomegalovirus (cmv)
CA2361987A1 (en) Goodpasture antigen binding protein
WO2003027149A1 (en) Antibody and use of the same
AU2003260392A1 (en) Method for enriching a prokaryotic dna
GB9816514D0 (en) Novel method
AU4908799A (en) Determination of the hydrophobic pulmonary surfactant protein sp-c
AR018045A1 (en) PLACENTARY PROTEIN 13 AND POLYPETIDE, DNA MOLECULA THAT CODIFIES THEM, ANTIBODIES ABLE TO LINK TO THEM, METHOD FOR DETECTION DECOMPLICATIONS RELATED TO PREGNANCY, RECOMBINANT METHOD FOR THE PRODUCTION OF DIAHA PROTECOEL AND A COMPLIANCE EQUIPMENT
RU98106385A (en) URINAL CARCINOMA COMPLEX TLP PEPTIDES AND THEIR ANTIBODIES
WO2002002620A3 (en) Crmp-5 (collapsin response-mediator protein) encoding nucleic acid, polypeptide and uses thereof
AU2525597A (en) Monoclonal antibodies binding human growth hormone (hgh)
WO2001098780A3 (en) Assay for detecting primary dna damage
EP1702984A3 (en) A method for detecting prostate cancer
WO2002096929A3 (en) Polypeptides reacting with hcv-infected patients' antibodies and uses
AU652474C (en) Assay methods and compositions for detecting serum proteases, particularly activated protein C